trending Market Intelligence /marketintelligence/en/news-insights/trending/joufrhuda81ukqaaaqmmua2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Aspen, Mylan enter deal to distribute medicines in Australia, New Zealand

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Aspen, Mylan enter deal to distribute medicines in Australia, New Zealand

Aspen Pharmacare Holdings Ltd. and Mylan NV entered a deal to distribute certain prescription and over-the-counter products in Australia and New Zealand.

The agreement was struck between Canonsburg, Pa.-based Mylan, Aspen unit Aspen Global Inc. and the South African company's Australian subsidiaries, Aspen said in a filing.

The deal also includes an option by generics-maker Mylan to buy the portfolio of products for about A$188 million. The portfolio recorded sales of A$55 million for the year ended June 30.

Aspen Pharmacare develops specialty, branded and generic pharmaceutical products worldwide.